• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每日ROX指数可预测接受高流量鼻导管吸氧治疗的COVID-19患者在未来24小时内是否会过渡到机械通气。

Daily ROX index can predict transitioning to mechanical ventilation within the next 24 h in COVID-19 patients on HFNC.

作者信息

de Carvalho Victor Côrtes Pourchet, da Silva Guimarães Bruno Leonardo, Fujihara Mellina Tamy Fagundes, Ceotto Victor Fraga, Turon Ricardo, Lugon Jocemir Ronaldo, Gismondi Ronaldo Altenburg Odebrecht Curi

机构信息

Department of Medicine, Medical School, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil.

Intensive Care Unit, Hospital Niteroi D'Or, Niteroi, Rio de Janeiro, Brazil.

出版信息

Am J Emerg Med. 2023 Nov;73:160-165. doi: 10.1016/j.ajem.2023.08.045. Epub 2023 Sep 1.

DOI:10.1016/j.ajem.2023.08.045
PMID:37688983
Abstract

INTRODUCTION

High flow nasal cannula (HFNC) is used to prevent invasive ventilation in COVID-19-associated hypoxemia. The respiratory rate‑oxygenation (ROX) index has been reported to predict failure of HFNC in patients with COVID-19 pneumonia during the intensive care unit stay when measured in first hours of therapy. However, the clinical course of ICU patients may change substantially in the first days of admission. The objective of this study was to investigate whether ROX index obtained in the first four days of ICU admission could predict the need for invasive respiratory support within the next 24 h of measurements.

METHODS

A retrospective cross-sectional study was performed using a database that included adult patients with COVID-19 pneumonia treated in the ICU. Patients were followed from ICU admission and ROX index was calculated daily on HFNC. Receiver operating characteristics curves (ROCs) were performed.

RESULTS

Two hundred forty-nine patients were enrolled, 48% of whom require mechanical ventilation (MV). The area under the ROC of the pooled 4-day values of the ROX index as a predictor of transition from HFNC to MV within 24 h of measurements was 0.86 (95%CI 0.83 to 0.88, P < 0.001) with a cutoff point of 4.06.

CONCLUSION

In COVID-19 patients in high flow nasal cannula, daily ROX index measurements successfully predicted transition to mechanical ventilation within the next 24 h.

摘要

引言

高流量鼻导管(HFNC)用于预防新型冠状病毒肺炎相关低氧血症患者进行有创通气。据报道,在重症监护病房(ICU)治疗的最初数小时内测量呼吸频率-氧合(ROX)指数,可预测新型冠状病毒肺炎患者使用HFNC失败的情况。然而,ICU患者的临床病程在入院后的头几天可能会发生显著变化。本研究的目的是调查在ICU入院的前四天获得的ROX指数是否能预测在接下来测量的24小时内是否需要有创呼吸支持。

方法

采用回顾性横断面研究,使用一个包含在ICU接受治疗的成年新型冠状病毒肺炎患者的数据库。从患者入住ICU开始进行随访,并每天计算其使用HFNC时的ROX指数。绘制受试者工作特征曲线(ROC)。

结果

共纳入249例患者,其中48%需要机械通气(MV)。作为测量后24小时内从HFNC过渡到MV的预测指标,ROX指数合并4天值的ROC曲线下面积为0.86(95%可信区间0.83至0.88,P<0.001),截断点为4.06。

结论

对于使用高流量鼻导管的新型冠状病毒肺炎患者,每日测量ROX指数可成功预测在接下来的24小时内是否会过渡到机械通气。

相似文献

1
Daily ROX index can predict transitioning to mechanical ventilation within the next 24 h in COVID-19 patients on HFNC.每日ROX指数可预测接受高流量鼻导管吸氧治疗的COVID-19患者在未来24小时内是否会过渡到机械通气。
Am J Emerg Med. 2023 Nov;73:160-165. doi: 10.1016/j.ajem.2023.08.045. Epub 2023 Sep 1.
2
Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.用于预测 COVID-19 患者和非 COVID-19 患者高流量鼻导管失败的呼吸频率-氧合(ROX)指数。
Am J Emerg Med. 2024 Jan;75:53-58. doi: 10.1016/j.ajem.2023.09.036. Epub 2023 Oct 14.
3
Predicting the successful application of high-flow nasal oxygen cannula in patients with COVID-19 respiratory failure: a retrospective analysis.预测高流量鼻氧管在 COVID-19 呼吸衰竭患者中的成功应用:一项回顾性分析。
Expert Rev Respir Med. 2023 Apr;17(4):319-328. doi: 10.1080/17476348.2023.2199157. Epub 2023 Apr 5.
4
Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study.COVID-19 患者急性低氧性呼吸衰竭的呼吸治疗选择:一项回顾性病例系列研究。
PeerJ. 2023 Apr 10;11:e15174. doi: 10.7717/peerj.15174. eCollection 2023.
5
COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.COVID-19 肺炎与 ROX 指数:为 ICU 外收治患者设定新阈值的时机。
Pulmonology. 2022 Jan-Feb;28(1):13-17. doi: 10.1016/j.pulmoe.2021.04.003. Epub 2021 May 7.
6
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.高流量鼻导管治疗 COVID-19:使用 ROX 指数预测成功。
Respir Care. 2021 Jun;66(6):909-919. doi: 10.4187/respcare.08631. Epub 2020 Dec 16.
7
Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.COVID-19 重症患者使用高流量鼻导管氧疗及高流量鼻导管氧疗失败的危险因素。
Respir Res. 2022 Dec 3;23(1):329. doi: 10.1186/s12931-022-02231-2.
8
The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.ROX 指数预测急性低氧性呼吸衰竭肺炎患者高流量鼻导管治疗结局的系统评价和荟萃分析。
BMC Pulm Med. 2022 Apr 1;22(1):121. doi: 10.1186/s12890-022-01914-2.
9
Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.预测高流量鼻导管吸氧对低氧性呼吸衰竭肺炎患者的疗效:ROX指数的应用价值。
J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022. Epub 2016 May 31.
10
Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.呼吸频率和氧合指数对冠状病毒病肺炎高流量鼻导管支持成功的可靠性:一项回顾性队列研究。
BMC Pulm Med. 2023 Aug 10;23(1):294. doi: 10.1186/s12890-023-02598-y.

引用本文的文献

1
Impact of Surgical Mask Placement Over High-Flow Nasal Cannula on Oxygenation Parameters in COVID-19 Patients Experiencing Hypoxemic Respiratory Failure.外科口罩置于高流量鼻导管上对新冠病毒肺炎低氧性呼吸衰竭患者氧合参数的影响
Cureus. 2024 Dec 17;16(12):e75871. doi: 10.7759/cureus.75871. eCollection 2024 Dec.